Proyectos de investigación
Comienza el contenido principal
Non-atherosclerotic thrombosis and multiorgan damage in Hutchinson-Gilford progeria syndrome: From mechanism to therapy
Enfermedades raras
Investigador Principal: Vicente Andrés García
Centro de investigación o Institución: Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid
Abstract
Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare genetic disease caused by progerin, a mutant form of the nuclear protein lamin A that provokes premature aging and death. From the first or second year of life, progerin-induced cell damage causes growth retardation and disease signs in multiple organs (alopecia, scleroderma, lipodystrophy, skeletal dysplasia, joint contractures, cardiovascular alterations). Although patients typically lack most traditional cardiovascular risk factors, they develop atherosclerosis and die in their teens mainly from myocardial infarction, heart failure, or stroke. Based on solid preliminary data, our groundbreaking hypothesis is that HGPS promotes thrombus formation unrelated to atherosclerotic plaque rupture/erosion, that compromises tissue microcirculation and perfusion and results in multiorgan injury including heart damage.
Anti-coagulant therapy starting early in life may thus prevent tissue degeneration and heart dysfunction, improving life quality and extending lifespan of HGPS patients. We will perform in vivo studies with HGPS mice to define molecular and cellular mechanisms as well as hematopoietic-intrinsic and -extrinsic factors that provoke thromboinflammatory processes in HGPS. To expedite translation from basic to clinical research, we will test the efficacy of anticoagulant drugs in HGPS mice, both alone and in combination with lonafarnib, the only drug approved by the US Federal Drug Administration and the European Medicines Agency for treating HGPS. Complementing these research actions, 3 HGPS patient associations will organize activities to promote patient engagement and the dissemination of results to a non-expert audience. In addition to their relevance to HGPS, the results of this project promise insight into normal aging and other pro-thrombotic diseases.
-
Actividades relacionadas
-
Proyectos relacionados
-
Noticias relacionadas
-
Publicaciones relacionadas
Actividades relacionadas
-
3
abr
2025
Conferencias Científicos extranjeros en España Madrid, jueves 3 de abril de 2025, 19:00 horas
-
5
jun
2025
Conferencias Científicos españoles en el mundo Madrid, jueves 5 de junio de 2025, 19:00 horas
-
25
sep
2025
Conferencias Arquitectos y militares en la España Ilustrada: Juan de Villanueva y Félix de Azara Madrid, jueves 25 de septiembre de 2025, 19:00 horas
Proyectos relacionados
- Desarrollo y Aplicación de saRNAs para el Tratamiento de Enfermedades Raras Monogénicas 2024 Investigador Principal: María Luisa Cayuela Fuentes
- Mejora del diagnóstico y del cribado neonatal de las enfermedades metabólicas hereditarias con el uso de la metabolómica no dirigida. 2024 Investigador Principal: Judit García Villoria Centro de investigación o Institución: Fundació Clínic per a la Recerca Biomèdica. Hospital Clínic. Barcelona
- Mechanisms for sustaining mitochondrial genome integrity and function during hematopoiesis. 2024 Investigador Principal: Ana Victoria Lechuga Vieco Centro de investigación o Institución: Institute for Research Biomedicina, IRB Barcelona
Noticias relacionadas
Publicaciones relacionadas
Fin del contenido principal